Literature DB >> 15700967

Paralog-selective ligands for bcl-2 proteins.

Anja C Gemperli1, Stacey E Rutledge, Abby Maranda, Alanna Schepartz.   

Abstract

There is considerable current interest in molecules that bind intra- or extracellular protein surfaces and inhibit protein-protein interactions. Previously we have reported that miniature proteins based on pancreatic-fold polypeptides can recognize even shallow alpha-helix binding clefts with high affinity and selectivity against unrelated proteins. One such miniature protein, PPBH3-1, binds the anti-apoptotic protein paralogs Bcl-2 and Bcl-XL with nanomolar affinity and a DeltaDeltaG = 1.2 kcal.mol-1 preference for Bcl-XL. Here we describe the directed evolution of PPBH3-1 into two new miniature proteins, PPBH3-5 and PPBH3-6, whose paralog specificity is reversed relative to PPBH3-1. PPBH3-5 and PPBH3-6 bind Bcl-2 with nanomolar affinity and a DeltaDeltaG = 0.9-1.3 kcal.mol-1 preference for Bcl-2 over Bcl-XL. Experiments with Bcl-XL variants suggest that PPBH3-5 and PPBH3-6 achieve high paralog specificity by exploiting subtle structural or electrostatic differences in the Bcl-2 and Bcl-XL molecular landscapes. PPBH3-5 and PPBH3-6 may have unique applications as early examples of nonnatural ligands that interact selectively with Bcl-2 proteins.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15700967     DOI: 10.1021/ja0441211

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  21 in total

1.  Design, synthesis and protein-targeting properties of thioether-linked hydrogen bond surrogate helices.

Authors:  Andrew B Mahon; Paramjit S Arora
Journal:  Chem Commun (Camb)       Date:  2011-09-28       Impact factor: 6.222

2.  beta-Peptides as inhibitors of protein-protein interactions.

Authors:  Joshua A Kritzer; Olen M Stephens; Danielle A Guarracino; Samuel K Reznik; Alanna Schepartz
Journal:  Bioorg Med Chem       Date:  2005-01-03       Impact factor: 3.641

3.  Enhanced metabolic stability and protein-binding properties of artificial alpha helices derived from a hydrogen-bond surrogate: application to Bcl-xL.

Authors:  Deyun Wang; Wei Liao; Paramjit S Arora
Journal:  Angew Chem Int Ed Engl       Date:  2005-10-14       Impact factor: 15.336

4.  Noncovalent modification of chymotrypsin surface using an amphiphilic polymer scaffold: implications in modulating protein function.

Authors:  Britto S Sandanaraj; Dharma Rao Vutukuri; Joseph M Simard; Akamol Klaikherd; Rui Hong; Vincent M Rotello; S Thayumanavan
Journal:  J Am Chem Soc       Date:  2005-08-03       Impact factor: 15.419

Review 5.  Targeting protein-protein interactions by rational design: mimicry of protein surfaces.

Authors:  Steven Fletcher; Andrew D Hamilton
Journal:  J R Soc Interface       Date:  2006-04-22       Impact factor: 4.118

6.  Development of selective inhibitors for anti-apoptotic Bcl-2 proteins from BHI-1.

Authors:  Chengguo Xing; Liangyou Wang; XiaoHu Tang; Yuk Y Sham
Journal:  Bioorg Med Chem       Date:  2006-12-14       Impact factor: 3.641

7.  Modeling backbone flexibility to achieve sequence diversity: the design of novel alpha-helical ligands for Bcl-xL.

Authors:  Xiaoran Fu; James R Apgar; Amy E Keating
Journal:  J Mol Biol       Date:  2007-05-05       Impact factor: 5.469

Review 8.  Inhibition of α-helix-mediated protein-protein interactions using designed molecules.

Authors:  Valeria Azzarito; Kérya Long; Natasha S Murphy; Andrew J Wilson
Journal:  Nat Chem       Date:  2013-03       Impact factor: 24.427

9.  Arginine topology controls escape of minimally cationic proteins from early endosomes to the cytoplasm.

Authors:  Jacob S Appelbaum; Jonathan R LaRochelle; Betsy A Smith; Daniel M Balkin; Justin M Holub; Alanna Schepartz
Journal:  Chem Biol       Date:  2012-07-27

10.  Reconstitution and engineering of apoptotic protein interactions on the bacterial cell surface.

Authors:  Jingjing Sun; Diya M Abdeljabbar; Nicole Clarke; Meghan L Bellows; Christodoulos A Floudas; A James Link
Journal:  J Mol Biol       Date:  2009-09-17       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.